Skip to main content
FinSpry Logo
FinSpry
FENC logo
FENC
(NASDAQ)
Fennec Pharmaceuticals Inc.
$6.42-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Fennec Pharmaceuticals (FENC) Stock Price & Financial Analysis

Fennec Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.25 - $6.55
52-Week High$9.92
52-Week Low$4.68
Open$6.30
Volume267.08K
Average Volume (3M)267.08K
Market Cap179.05M
Shares Outstanding27.89M
Price to Sales (P/S)4.61
EV/EBITDA-47.19
Revenue (TTM)38.79M
Net Income (TTM)-6.94M
EPS (TTM)$-0.25
Profit Margin-17.89%
Operating Margin-12.15%
50-Day MA$7.73
200-Day MA$8.19
52-Week Change15.91%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Fennec Pharmaceuticals

What is the current stock price for FENC?

As of the latest trading session, FENC stock trades at $6.42. The 52-week range is $4.68–$9.92, with a day range of $6.25–$6.55.

What is the P/E ratio for FENC?

The P/E ratio (Price-to-Earnings) for FENC is shown in the Key Statistics section. This valuation metric helps compare Fennec Pharmaceuticals Inc. to industry peers.

Does FENC pay dividends?

Fennec Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FENC?

Based on 1 analyst, the consensus for FENC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FENC?

Fennec Pharmaceuticals's market capitalization is $179.0M, classifying it as a micro-cap company. Fennec Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.